Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cc98dfd7f88a3cfefcb5003434a767f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e8398c186c67000a7f5d4df2e9df0e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7f8d3528ecc6e8310a349278e600e3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99c9f170d88ca0fb05c7ac9d86168b46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247f5a1ca40e485dd2681a7ce6cc4ce3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ac1f5303b97b57fafbf6b90b89b46d |
publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015010596-A1 |
titleOfInvention |
Prognosis diagnosis method of breast cancer |
abstract |
The present invention provides a prognosis diagnosis method of breast cancer, comprising: measuring the expression quantity of ER-α36 in tumor tissue of a breast cancer patient, wherein when ER-α36 is high in expression, it indicates that the patient has the risk of breast cancer recurrence in situ or metastasis. The method of the present invention has guiding significance in a prognosis for a breast cancer patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109596830-A |
priorityDate |
2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |